Nektar Therapeutics
NKTR
$1.32
Share price
0.00%
Change (1 day)
76.00%
Change (1 year)
Categories
Operating Margin for Nektar Therapeutics (NKTR)
Operating Margin as of April 2024 (TTM): -396.48%
According to Nektar Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -396.48%. At the end of 2021 the company had an Operating Margin of -513.49%.
Operating Margin history for Nektar Therapeutics from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -513.49% | 76.87% |
| 2020 | -290.32% | -24.38% |
| 2019 | -383.93% | -771.07% |
| 2018 | 57.21% | -283.24% |
| 2017 | -31.22% | -66.16% |
| 2016 | -92.27% | 163.97% |
| 2015 | -34.96% | 28.9% |
| 2014 | -27.12% | -74.72% |
| 2013 | -107.28% | -49.19% |
| 2012 | -211.17% | 13.52% |
| 2011 | -186.01% | 698.31% |
| 2010 | -23.30% | -83.69% |
| 2009 | -142.88% | -466.66% |
| 2008 | 38.97% | -438.26% |
| 2007 | -11.52% | -83.71% |
| 2006 | -70.70% | -51.8% |
| 2005 | -146.70% | 64.27% |
| 2004 | -89.31% | 104.01% |
| 2003 | -43.77% | -58.52% |
| 2002 | -105.52% | -26.16% |
| 2001 | -142.90% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -105.77% | 🇺🇸 USA |
 Pfizer PFE | 34.61% | -108.73% | 🇺🇸 USA |
 Amgen AMGN | 34.59% | -108.72% | 🇺🇸 USA |
 Baxter BAX | -19.01% | -95.21% | 🇺🇸 USA |
 Merck MRK | 27.73% | -106.99% | 🇺🇸 USA |
 AstraZeneca AZN | 5.63% | -101.42% | 🇬🇧 UK |
 Richardson Electronics RELL | 10.65% | -102.69% | 🇺🇸 USA |
 Alkermes ALKS | -15.04% | -96.21% | 🇮🇪 Ireland |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.